Correlation Between TRACON Pharmaceuticals and Immix Biopharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both TRACON Pharmaceuticals and Immix Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TRACON Pharmaceuticals and Immix Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TRACON Pharmaceuticals and Immix Biopharma, you can compare the effects of market volatilities on TRACON Pharmaceuticals and Immix Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TRACON Pharmaceuticals with a short position of Immix Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of TRACON Pharmaceuticals and Immix Biopharma.

Diversification Opportunities for TRACON Pharmaceuticals and Immix Biopharma

0.74
  Correlation Coefficient

Poor diversification

The 3 months correlation between TRACON and Immix is 0.74. Overlapping area represents the amount of risk that can be diversified away by holding TRACON Pharmaceuticals and Immix Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immix Biopharma and TRACON Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TRACON Pharmaceuticals are associated (or correlated) with Immix Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immix Biopharma has no effect on the direction of TRACON Pharmaceuticals i.e., TRACON Pharmaceuticals and Immix Biopharma go up and down completely randomly.

Pair Corralation between TRACON Pharmaceuticals and Immix Biopharma

Given the investment horizon of 90 days TRACON Pharmaceuticals is expected to under-perform the Immix Biopharma. In addition to that, TRACON Pharmaceuticals is 1.47 times more volatile than Immix Biopharma. It trades about -0.03 of its total potential returns per unit of risk. Immix Biopharma is currently generating about 0.03 per unit of volatility. If you would invest  203.00  in Immix Biopharma on August 31, 2024 and sell it today you would earn a total of  8.00  from holding Immix Biopharma or generate 3.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy71.39%
ValuesDaily Returns

TRACON Pharmaceuticals  vs.  Immix Biopharma

 Performance 
       Timeline  
TRACON Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days TRACON Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, TRACON Pharmaceuticals is not utilizing all of its potentials. The newest stock price disarray, may contribute to short-term losses for the investors.
Immix Biopharma 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Immix Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Immix Biopharma may actually be approaching a critical reversion point that can send shares even higher in December 2024.

TRACON Pharmaceuticals and Immix Biopharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with TRACON Pharmaceuticals and Immix Biopharma

The main advantage of trading using opposite TRACON Pharmaceuticals and Immix Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TRACON Pharmaceuticals position performs unexpectedly, Immix Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immix Biopharma will offset losses from the drop in Immix Biopharma's long position.
The idea behind TRACON Pharmaceuticals and Immix Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios